- Home
- AVIR vs SSBK Comparison
AVIR vs SSBK Comparison
Compare AVIR & SSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- SSBK
- Stock Information
- Founded
- AVIR 2012
- SSBK 2007
- Country
- AVIR United States
- SSBK United States
- Employees
- AVIR N/A
- SSBK N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- SSBK Commercial Banks
- Sector
- AVIR Health Care
- SSBK Finance
- Exchange
- AVIR Nasdaq
- SSBK Nasdaq
- Market Cap
- AVIR 276.9M
- SSBK 258.6M
- IPO Year
- AVIR 2020
- SSBK 2021
- Fundamental
- Price
- AVIR $3.25
- SSBK $36.83
- Analyst Decision
- AVIR Hold
- SSBK Buy
- Analyst Count
- AVIR 1
- SSBK 1
- Target Price
- AVIR $6.88
- SSBK $36.00
- AVG Volume (30 Days)
- AVIR 178.7K
- SSBK 24.4K
- Earning Date
- AVIR 11-07-2024
- SSBK 10-21-2024
- Dividend Yield
- AVIR N/A
- SSBK 0.96%
- EPS Growth
- AVIR N/A
- SSBK N/A
- EPS
- AVIR N/A
- SSBK 3.52
- Revenue
- AVIR N/A
- SSBK $87,115,000.00
- Revenue This Year
- AVIR N/A
- SSBK N/A
- Revenue Next Year
- AVIR N/A
- SSBK $11.75
- P/E Ratio
- AVIR N/A
- SSBK $10.36
- Revenue Growth
- AVIR N/A
- SSBK 1.89
- 52 Week Low
- AVIR $2.81
- SSBK $22.13
- 52 Week High
- AVIR $4.60
- SSBK $37.86
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- SSBK 65.67
- Support Level
- AVIR $3.10
- SSBK $35.21
- Resistance Level
- AVIR $3.48
- SSBK $36.94
- Average True Range (ATR)
- AVIR 0.13
- SSBK 1.35
- MACD
- AVIR -0.01
- SSBK 0.10
- Stochastic Oscillator
- AVIR 29.52
- SSBK 84.99
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About SSBK Southern States Bancshares Inc.
Southern States Bancshares Inc is a full-service community banking institution, that offers an array of deposit, loan, and other banking-related products and services to businesses and individuals in communities. It has three portfolio segments Real estate, Commercial and industrial, Consumer and other.